AI-generated summary
The authors studied whether low-energy infrared laser radiation combined with cyclophosphane could enhance the drug's antitumor effect in rats bearing sarcoma-45 tumors. They report that certain laser exposure modes stimulated non-specific antitumor resistance, reduced the drug's damaging effects, and inhibited refractory leukopenia and intoxication. These findings come from an animal study described only briefly in the abstract.
- Who or what was studied
- Sarcoma-45-bearing rats
- Limits stated in the abstract
- The abstract describes an animal study only and does not report sample size, control groups, or statistical details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.